Discuss GLP-1s and related metabolic research, compare published evidence and share experiences with enough context to be useful.
Find the right discussion
Use the dedicated sections for Tirzepatide, Semaglutide, Retatrutide, Cagri & CagriSema, Tesofensine, Survodutide, Mazdutide, and Eloralintide & Loretta. This parent category is for broader questions and comparisons that genuinely involve more than one section. The grouping is a navigation aid; it does not mean that every substance has the same mechanism or evidence base.
A useful comparison identifies the substances, the question being compared and the source of the information. Results from different populations or study lengths need context. A personal experience can be valuable without being proof that another person will have the same result.
Background reading
Start with the myPeptides monographs for semaglutide, tirzepatide and retatrutide. Each compound section links to the relevant background pages.
For blends, write out the components and the label composition. For example, our Loretta section distinguishes Eloralintide + Retatrutide, 10 / 2.5, from either individual substance. A blend name alone is not enough to identify what is being discussed.